{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:48:59Z","timestamp":1770814139499,"version":"3.50.1"},"reference-count":73,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"F. Hoffmann-La Roche Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2026,1,2]]},"DOI":"10.1080\/13543784.2026.2613290","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T19:06:31Z","timestamp":1769713591000},"page":"19-28","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Optimizing dose selection in oncology: the rationale for the clinical dose selection of giredestrant, an oral selective estrogen receptor degrader"],"prefix":"10.1080","volume":"35","author":[{"given":"Elgene","family":"Lim","sequence":"first","affiliation":[{"name":"University of New South Wales","place":["Darlinghurst, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajie","family":"Yu","sequence":"additional","affiliation":[{"name":"Genentech Inc","place":["South San Francisco, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunze","family":"Li","sequence":"additional","affiliation":[{"name":"Genentech Inc","place":["South San Francisco, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona D.","family":"Shah","sequence":"additional","affiliation":[{"name":"Genentech Inc","place":["South San Francisco, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Eng-Wong","sequence":"additional","affiliation":[{"name":"Genentech Inc","place":["South San Francisco, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo Diego","family":"P\u00e9rez-Moreno","sequence":"additional","affiliation":[{"name":"Genentech Inc","place":["South San Francisco, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Komal","family":"Jhaveri","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center","place":["New York, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2109826"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00371"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1337"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1144056"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3373"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3298"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/1758834015608993"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-023-00523-4"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-021-01462-3"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.103114"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.14694\/EdBook_AM.2013.33.271"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.7336"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.0261"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40487-017-0046-2"},{"key":"e_1_3_6_16_1","unstructured":"AstraZeneca UK Limited. FASLODEX\u00ae (fulvestrant). Prescribing information. 2021 [cited 2025 Jun]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/021344s044lbl.pdf"},{"key":"e_1_3_6_17_1","unstructured":"Drugs.com. FDA approves new dosing for faslodex. 2010 [cited 2025 Jun]. Available from: https:\/\/www.drugs.com\/newdrugs\/fda-approves-new-dosing-faslodex-fulvestrant-metastatic-breast-cancer-hr-postmenopausal-women-2292.html"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S106629"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c00847"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-1796"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31668-8"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/17588359221083956"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.08.547"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS22-OT1-04-01"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.04.012"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.1032"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS22-GS3-02"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS23-RF01-01"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.02272"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-020-01333-3"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00338"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.1050"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS23-PS15-09"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.1021"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1158\/1557-3265.SABCS24-GS1-01"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(22)00896-6"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS23-PO4-04-12"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS23-PS15-04"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS1135"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.09.559"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.10.207"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS22-GS3-03"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.09.567"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.101394"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103240"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS23-PS15-03"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.1061"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01500"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00268-1"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.577"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.TPS1103"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS1130"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.TPS1119"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.TPS616"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS19-PD7-05"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.CRC-23-0324"},{"issue":"2","key":"e_1_3_6_57_1","first-page":"2982","article-title":"Project optimus: principles, challenges, and a paradigm shift in dose optimization for cancer therapies","volume":"7","author":"Hojouj M","year":"2025","unstructured":"Hojouj M, Landers D, Cruz R, et al. Project optimus: principles, challenges, and a paradigm shift in dose optimization for cancer therapies. J Pharm Drug Devel. 2025;7(2):2982\u20133013.","journal-title":"J Pharm Drug Devel"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS23-PO5-14-11"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.1017"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS21-PD13-07"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS23-PO4-04-11"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-14-0697"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.1023"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1148\/rg.220143"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30458-7"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.06.026"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS21-P5-18-07"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13491"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.1059"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS23-PS17-07"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1200\/PO.19.00032"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S62666"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-008-9074-z"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0807650"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2026.2613290","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T12:50:10Z","timestamp":1770382210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2026.2613290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"alternative-id":["10.1080\/13543784.2026.2613290"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2026.2613290","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-07-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}